Dehydrodiisoeugenol, an isoeugenol dimer, inhibits lipopolysaccharide-stimulated nuclear factor kappa B activation and cyclooxygenase-2 expression in macrophages
- 1 February 2005
- journal article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 434 (2), 326-332
- https://doi.org/10.1016/j.abb.2004.11.013
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 21 references indexed in Scilit:
- The Many Roles of Computation in Drug DiscoveryScience, 2004
- Protein Kinase Inhibitors: Insights into Drug Design from StructureScience, 2004
- Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicityToxicology, 2002
- Chemoprotection by Phenolic AntioxidantsPublished by Elsevier ,2002
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Involvement of NF‐κB in the regulation of cyclooxygenase‐2 protein expression in LPS‐stimulated J774 macrophagesFEBS Letters, 1997
- Skin Sensitization to Eugenol and Isoeugenol in Mice: Possible Metabolic Pathways Involving ortho-Quinone and Quinone Methide IntermediatesChemical Research in Toxicology, 1997
- Nuclear factor kappa B, a mediator of lipopolysaccharide effectsImmunobiology, 1993
- Possible origin of the skin sensitization potential of isoeugenol and related compoundsContact Dermatitis, 1992
- Ultraviolet irradiation-induced inflammation: effects of steroid and nonsteroid anti-inflammatory agentsArchives of Dermatology, 1979